Heart and Vessels

, Volume 34, Issue 10, pp 1631–1638 | Cite as

History of gastroesophageal reflux disease in patients with suspected coronary artery disease

  • Hiroki TeragawaEmail author
  • Chikage Oshita
  • Tomohiro Ueda
Original Article


It is well known that patients with gastroesophageal reflux disease (GERD) experience GERD-related chest pain, but little is known about the relationship between GERD and coronary artery disease (CAD). We evaluated medical history of GERD in patients with suspected CAD and its association with types of CAD. We enrolled 236 patients who underwent coronary angiography (CAG). We assessed past medical history of each patient, making note of esophageal or stomach diseases such as GERD including reflux esophagitis and non-erosive reflux disease. The patients were divided into the following three subgroups based on the CAG results. Group I, patients with o-CAD (> 50% stenosis with ischemic findings, n = 141); Group II, patients with vasospastic angina (VSA, with positive spasm provocation test without organic coronary stenosis, n = 52); and Group III, patients without organic coronary stenosis or VSA (n = 43). Group I included more men than women (p < 0.001) and the frequencies of smoking, lipid disorders, and diabetes mellitus in this group were higher than those in the other groups (p < 0.01). The frequency of medical history of GERD was significantly higher in Group II (21%) than in Group I (3%) or Group III (7%, p < 0.0001). Logistic regression analysis showed that a medical history of GERD (OR 7.8; p < 0.01) was one of the factors associated with the presence of VSA. Our findings showed that a medical history of GERD was frequently observed in approximately one-fifth of patients with VSA, indicating that VSA may be present in patients with chest pain and a medical history of GERD.


Acetylcholine Coronary artery disease Non-erosive gastroesophageal reflux disease Non-cardiac chest pain Vasospastic angina 



We acknowledge all the staff in the Cardiovascular Ward and Catheterization laboratory room at JR Hiroshima Hospital.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.


  1. 1.
    JCS Joint Working Group (2014) Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J 78(11):2779–2801CrossRefGoogle Scholar
  2. 2.
    Eslick GD, Coulshed DS, Talley NJ (2002) Review article: the burden of illness of non-cardiac chest pain. Aliment Pharmacol Ther 16(7):1217–1223CrossRefGoogle Scholar
  3. 3.
    Fox M, Forgacs I (2006) Gastro-oesophageal reflux disease. BMJ (Clin Res ed) 332(7533):88–93CrossRefGoogle Scholar
  4. 4.
    Richter JE (1996) Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management. Gastroenterol Clin N Am 25(1):75–102CrossRefGoogle Scholar
  5. 5.
    Richter JE (1996) Angina-like chest pain. Heart, esophagus, or something else? Chest 109(5):1139–1140CrossRefGoogle Scholar
  6. 6.
    Teragawa H, Fujii Y, Uchimura Y, Oshita C, Ueda T, Kihara Y (2017) Usefulness of a pressure wire for the diagnosis of vasospastic angina during a spasm provocation test. J Clin Exp Res Cardiol 3(2):203Google Scholar
  7. 7.
    Teragawa H, Fujii Y, Oshita C, Uchimura Y, Ueda T (2017) What factors contribute to chest symptoms during exercise in patients with vasospastic angina? Angiology 5(3):202Google Scholar
  8. 8.
    Teragawa H, Fujii Y, Oshita C, Ueda T (2017) Importance of the spasm provocation test in diagnosing and clarifying the activity of vasospastic angina. Interv Cardiol J 3(2):58CrossRefGoogle Scholar
  9. 9.
    Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G (2001) Magnesium causes nitric oxide independent coronary artery vasodilation in humans. Heart 86(2):212–216CrossRefGoogle Scholar
  10. 10.
    Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992CrossRefGoogle Scholar
  11. 11.
    National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266Google Scholar
  12. 12.
    Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502Google Scholar
  13. 13.
    National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106(25):3143–3421CrossRefGoogle Scholar
  14. 14.
    Teragawa H, Kato M, Kurokawa J, Yamagata T, Matsuura H, Chayama K (2001) Endothelial dysfunction is an independent factor responsible for vasospastic angina. Clin Sci (Lond) 101(6):707–713CrossRefGoogle Scholar
  15. 15.
    Teragawa H, Fukuda Y, Matsuda K, Higashi Y, Yamagata T, Matsuura H, Chayama K (2002) Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 165(1):145–152CrossRefGoogle Scholar
  16. 16.
    Lenfant C (2010) Chest pain of cardiac and noncardiac origin. Metabolism 59(Suppl 1):S41–46CrossRefGoogle Scholar
  17. 17.
    Cheung TK, Lim PW, Wong BC (2007) The view of gastroenterologists on non-cardiac chest pain in Asia. Aliment Pharmacol Ther 26(4):597–603CrossRefGoogle Scholar
  18. 18.
    Karlaftis A, Karamanolis G, Triantafyllou K, Polymeros D, Gaglia A, Triantafyllou M, Papanikolaou IS, Ladas SD (2013) Clinical characteristics in patients with non-cardiac chest pain could favor gastroesophageal reflux disease diagnosis. Ann Gastroenterol 26(4):314–318Google Scholar
  19. 19.
    George N, Abdallah J, Maradey-Romero C, Gerson L, Fass R (2016) Review article: the current treatment of non-cardiac chest pain. Aliment Pharmacol Ther 43(2):213–239CrossRefGoogle Scholar
  20. 20.
    Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM (1996) Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. Am J Gastroenterol 91(9):1749–1757Google Scholar
  21. 21.
    Fass R (2007) Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol 41(2):131–137CrossRefGoogle Scholar
  22. 22.
    Kawara F, Fujita T, Morita Y, Uda A, Masuda A, Saito M, Ooi M, Ishida T, Kondo Y, Yoshida S, Okuno T, Yano Y, Yoshida M, Kutsumi H, Hayakumo T, Yamashita K, Hirano T, Hirai M, Azuma T (2017) Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy. World J Gastroenterol 23(11):2060–2067CrossRefGoogle Scholar
  23. 23.
    Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S (2017) Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia. Biomed Rep 6(2):175–180CrossRefGoogle Scholar
  24. 24.
    Eslick GD, Talley NJ (2008) Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil 20(9):989–997CrossRefGoogle Scholar
  25. 25.
    Savarino E, Zentilin P, Savarino V (2013) NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol 10(6):371–380CrossRefGoogle Scholar
  26. 26.
    Kawano H, Motoyama T, Hirai N, Kugiyama K, Ogawa H, Yasue H (2001) Estradiol supplementation suppresses hyperventilation-induced attacks in postmenopausal women with variant angina. J Am Coll Cardiol 37(3):735–740CrossRefGoogle Scholar
  27. 27.
    Kawana A, Takahashi J, Takagi Y, Yasuda S, Sakata Y, Tsunoda R, Ogata Y, Seki A, Sumiyoshi T, Matsui M, Goto T, Tanabe Y, Sueda S, Kubo N, Momomura S, Ogawa H, Shimokawa H, Japanese Coronary Spasm A (2013) Gender differences in the clinical characteristics and outcomes of patients with vasospastic angina—a report from the Japanese Coronary Spasm Association. Circ J 77(5):1267–1274CrossRefGoogle Scholar
  28. 28.
    Sueda S, Miyoshi T, Sasaki Y, Sakaue T, Habara H, Kohno H (2016) Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test. Heart Vessels 31(3):322–329CrossRefGoogle Scholar
  29. 29.
    Frieling T (2018) Non-Cardiac Chest Pain. Visc Med 34(2):92–96Google Scholar
  30. 30.
    Chow SL, Luzier AB, DiTusa L, Snyder BD, Izzo JL Jr (2001) Acid-suppressive therapy use associated with antihypertensive agents. J Clin Pharmacol 41(7):750–756CrossRefGoogle Scholar
  31. 31.
    Friedenberg FK, Hanlon A, Vanar V, Nehemia D, Mekapati J, Nelson DB, Richter JE (2010) Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey. Dig Dis Sci 55(7):1911–1917CrossRefGoogle Scholar
  32. 32.
    Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H, Ino K, Horikoshi T, Sugiyama T, Toki M, Ohwada T, Mori M (2004) Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 39(9):888–891CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Cardiovascular MedicineJR Hiroshima HospitalHiroshimaJapan

Personalised recommendations